Lumirelax en es it fr

Lumirelax Brand names, Lumirelax Analogs

Lumirelax Brand Names Mixture

  • No information avaliable

Lumirelax Chemical_Formula


Lumirelax RX_link

Lumirelax fda sheet

Lumirelax msds (material safety sheet)

Lumirelax Synthesis Reference

No information avaliable

Lumirelax Molecular Weight

226.274 g/mol

Lumirelax Melting Point

50.5 oC

Lumirelax H2O Solubility

Sparingly soluble

Lumirelax State


Lumirelax LogP


Lumirelax Dosage Forms

Capsules for oral administration (250 mg)

Lumirelax Indication

Used as a diagnostic drug for testing hypothalamic-pituitary ACTH function.

Lumirelax Pharmacology

Metopirone is an inhibitor of endogenous adrenal corticosteroid synthesis.

Lumirelax Absorption

Absorbed rapidly and well when administered orally. Peak plasma concentrations are usually reached 1 hour after administration.

Lumirelax side effects and Toxicity

Oral LD50 in rats is 521 mg/kg. One case has been recorded in which a 6-year-old girl died after two doses of Metopirone, 2 g. Symptoms of overdose include cardiac arrhythmias, hypotension, dehydration, anxiety, confusion, weakness, impairment of consciousness, nausea, vomiting, epigastric pain, and diarrhea.

Lumirelax Patient Information

Lumirelax Organisms Affected

Humans and other mammals